2011 International Expert Meeting on Large Congenital Melanocytic Nevi

描述(由申请人提供)：在过去的几年里，在理解巨大的先天性黑色素细胞痣(CMN)及其相关疾病的起源和临床处理方面取得了相当大的进展。遗传学、细胞生物学、流行病学和治疗研究的新成果伴随着由美国和欧洲国家的团体带头的世界各地的患者倡议所做的巨大努力。所有这些参与者之间存在着巨大的协同潜力。在德国图宾根举行的会议旨在使该领域的杰出研究人员和医生能够交流基础生物学和临床医学方面的最新信息，有时甚至是未发表的信息。这次会议将促进和促进与会者之间的新颖、跨学科和国际合作的协调。美国和欧洲主要倡导团体的领导人将出席会议，代表患者参与那些将在会议期间为其奠定基础的翻译研究项目。这些结果将对改善这种毁容和潜在威胁生命的疾病的诊断和治疗做出重要贡献。

DESCRIPTION (provided by applicant): In the last years, considerable progress has been made in understanding the origins and clinical management of large congenital melanocytic nevi (CMN) and its related disorders. New results from genetics, cell biology, epidemiology, and therapeutic research are flanked by enormous efforts made by patient initiatives around the world, spearheaded by groups in the U.S. and European countries. There is enormous potential for synergy between all of these players. The conference in Tubingen, Germany aims to enable the exchange of the most up-to-date, sometimes unpublished information from basic biology and clinical medicine among outstanding researchers and physicians in the field. This conference will foster and enable the coordination of novel, interdisciplinary and international collaborations among participants. The leadership of major U.S. and European advocacy groups will attend the conference, to represent patient participation in those translational research projects for which the groundwork will be laid during the conference. These outcomes will make important contributions to the improvement of diagnosis and treatment for patients with this disfiguring and potentially life-threatening disease.